Increased risk of adefovir resistance in patients with lamivudine-resistant chronic hepatitis B after 48 weeks of adefovir dipivoxil monotherapy. (Q54599747)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Increased risk of adefovir resistance in patients with lamivudine-resistant chronic hepatitis B after 48 weeks of adefovir dipivoxil monotherapy. |
scientific article |
Statements
Increased risk of adefovir resistance in patients with lamivudine-resistant chronic hepatitis B after 48 weeks of adefovir dipivoxil monotherapy. (English)
1 reference
Yoon-Seon Lee
1 reference
Dong Jin Suh
1 reference
Young-Suk Lim
1 reference
Suk Won Jung
1 reference
Kang Mo Kim
1 reference
Han Chu Lee
1 reference
Young-Hwa Chung
1 reference
Yung Sang Lee
1 reference
Wangdon Yoo
1 reference
Soo-Ok Kim
1 reference
1 June 2006
1 reference
1 reference
43
1 reference
1385-1391
1 reference
6
1 reference
1 reference
Identifiers
1 reference